Cboe Global Markets Reports Results for Third Quarter 2026

Cboe Global Markets reported Q3 2026 net revenue of $712.2 million, up 18% year over year; diluted EPS rose 43% to a record $4.08 and adjusted diluted EPS increased 36% to $3.63. The company raised its 2026 organic total net revenue growth target to “high teens” and Data Vantage growth target to “mid teens,” while lowering adjusted operating expense guidance to $830–$845 million. Derivatives net revenue grew 22%, supported by a 24% increase in index options average daily volume; Cboe also announced a $550 million increase to its share repurchase authorization.

Analysis

CBOE | Earnings quality is stronger than the headline EPS, but the volume mix is the key risk. The divestiture gain and lower reported tax rate flatter GAAP EPS; adjusted EPS growth and lower expense guidance still support genuine operating leverage. The less obvious offset: options market share slipped despite strong index activity, while higher revenue per contract reflects richer index mix. That is attractive while 0DTE demand persists, but makes revenue more exposed to a reversal in volatility-driven trading and does not establish broad-based share gains. Watch index options ADV, RPC, and market share together—not volume alone.

The S&P license extension reduces long-dated franchise uncertainty, while faster Data Vantage growth adds a less transaction-sensitive earnings leg. Conversely, the November company-KPI event-contract launch is an unproven catalyst: SEC approval is not evidence of customer adoption, and product uptake, clearing economics, and regulatory durability remain to be demonstrated. The CAT receivable reserve is a discrete reminder that infrastructure funding can create credit/collectability exposure.

Timing: Immediate reaction may over-credit record GAAP EPS; assess the call for volume sustainability and market-share explanations. Over 1–3 months, test event-contract engagement and whether guidance translates into realized organic growth. Over 6–18 months, the thesis depends on recurring data growth and preserving premium index-options economics through a less volatile tape. A deterioration in index ADV/RPC, continued options share losses, or a guidance rollback would falsify the constructive view.

Key Decisions for Investors

• Prefer a measured long CBOE on post-earnings consolidation rather than chasing the EPS headline. The positive case is adjusted earnings growth, raised organic targets, and expense discipline; the principal downside is multiple compression if volatility-driven index activity normalizes. No price target without current valuation and consensus data.
• For the next 1–3 months, monitor index options ADV and RPC, total options market share, and Data Vantage organic growth. Treat sustained share losses alongside weaker index activity or RPC as a thesis warning; a launch announcement alone is not a buy signal for the event-contract opportunity.
• Treat the new repurchase authorization as incremental capital-allocation flexibility, not a near-term earnings catalyst. Verify actual repurchase pace and cash use before assigning it material per-share support.
• Key falsifiers: management reduces the raised growth outlook; index-options RPC or ADV weakens materially as volatility cools; or total options market share continues to decline without an offset from Data Vantage or other segments.